Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2003 2
2005 2
2006 2
2007 6
2008 6
2009 4
2010 6
2011 12
2012 13
2013 8
2014 12
2015 8
2016 7
2017 7
2018 2
2019 8
2020 3
2021 12
2022 17
2023 15
2024 8
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

142 results

Results by year

Filters applied: . Clear all
Page 1
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial.
Bidard FC, Kaklamani VG, Neven P, Streich G, Montero AJ, Forget F, Mouret-Reynier MA, Sohn JH, Taylor D, Harnden KK, Khong H, Kocsis J, Dalenc F, Dillon PM, Babu S, Waters S, Deleu I, García Sáenz JA, Bria E, Cazzaniga M, Lu J, Aftimos P, Cortés J, Liu S, Tonini G, Laurent D, Habboubi N, Conlan MG, Bardia A. Bidard FC, et al. Among authors: montero aj. J Clin Oncol. 2022 Oct 1;40(28):3246-3256. doi: 10.1200/JCO.22.00338. Epub 2022 May 18. J Clin Oncol. 2022. PMID: 35584336 Free PMC article. Clinical Trial.
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study.
Martín M, Lim E, Chavez-MacGregor M, Bardia A, Wu J, Zhang Q, Nowecki Z, Cruz FM, Safin R, Kim SB, Schem C, Montero AJ, Khan S, Bandyopadhyay R, Moore HM, Shivhare M, Patre M, Martinalbo J, Roncoroni L, Pérez-Moreno PD, Sohn J; acelERA Breast Cancer Study Investigators. Martín M, et al. Among authors: montero aj. J Clin Oncol. 2024 Jun 20;42(18):2149-2160. doi: 10.1200/JCO.23.01500. Epub 2024 Mar 27. J Clin Oncol. 2024. PMID: 38537155 Free PMC article. Clinical Trial.
Allostatic Load/Chronic Stress and Cardiovascular Outcomes in Patients Diagnosed With Breast, Lung, or Colorectal Cancer.
Stabellini N, Cullen J, Bittencourt MS, Moore JX, Sutton A, Nain P, Hamerschlak N, Weintraub NL, Dent S, Tsai MH, Banerjee A, Ghosh AK, Sadler D, Coughlin SS, Barac A, Shanahan J, Montero AJ, Guha A. Stabellini N, et al. Among authors: montero aj. J Am Heart Assoc. 2024 Jul 16;13(14):e033295. doi: 10.1161/JAHA.123.033295. Epub 2024 Jul 9. J Am Heart Assoc. 2024. PMID: 38979791 Free PMC article.
Adverse social determinants of health elevate uncontrolled hypertension risk: a cardio-oncology prospective cohort study.
Nain P, Stabellini N, Makram OM, Rast J, Yerraguntla S, Gopu G, Bhave A, Seth L, Patel V, Jiang S, Malik S, Shetewi A, Montero AJ, Cullen J, Agarwal N, Wang X, Ky B, Baldassarre LA, Weintraub NL, Harris RA, Guha A. Nain P, et al. Among authors: montero aj. JNCI Cancer Spectr. 2024 Sep 2;8(5):pkae064. doi: 10.1093/jncics/pkae064. JNCI Cancer Spectr. 2024. PMID: 39115393 Free PMC article.
Building Quality from the Ground Up in a Cancer Center.
Babar A, Montero AJ. Babar A, et al. Among authors: montero aj. 2021 Oct 29. In: Aljurf M, Majhail NS, Koh MBC, Kharfan-Dabaja MA, Chao NJ, editors. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 14. 2021 Oct 29. In: Aljurf M, Majhail NS, Koh MBC, Kharfan-Dabaja MA, Chao NJ, editors. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 14. PMID: 36122085 Free Books & Documents. Review.
Multicriteria decision analysis in oncology.
Adunlin G, Diaby V, Montero AJ, Xiao H. Adunlin G, et al. Among authors: montero aj. Health Expect. 2015 Dec;18(6):1812-26. doi: 10.1111/hex.12178. Epub 2014 Mar 17. Health Expect. 2015. PMID: 24635949 Free PMC article. Review.
PET/CT Variants and Pitfalls in Breast Cancers.
Kikano EG, Avril S, Marshall H, Jones RS, Montero AJ, Avril N. Kikano EG, et al. Among authors: montero aj. Semin Nucl Med. 2021 Sep;51(5):474-484. doi: 10.1053/j.semnuclmed.2021.04.005. Epub 2021 Jun 2. Semin Nucl Med. 2021. PMID: 34088473 Review.
A Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor-Positive Breast Cancer: The BRACELET-01/PrE0113 Study.
Clark AS, Zhao F, Klein P, Montero AJ, Falkson C, Krill-Jackson E, Rowland K, Sardesai S, Incorvati J, Dillon P, Wolff AC, Trauger R, Heineman TC, Coffey MC, Miller KD. Clark AS, et al. Among authors: montero aj. Clin Cancer Res. 2025 Jul 1;31(13):2655-2662. doi: 10.1158/1078-0432.CCR-24-2701. Clin Cancer Res. 2025. PMID: 40300087 Free PMC article. Clinical Trial.
142 results